Medtronic reports 18.3 percent preliminary MiniMed proration factor: stock at EUR 82.65 pre-market
Published on 10/13/2026 at 08:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Medtronic said its MiniMed exchange offer was oversubscribed.
- The preliminary proration factor was estimated at 18.3 percent.
- Medtronic stock was at EUR 82.65 at Lang & Schwarz at 8:10 a.m. CEST.
Medtronic plc reported on October 12, 2026, that its MiniMed exchange offer was oversubscribed and estimated that 18.3 percent of tendered Medtronic ordinary shares would be exchanged. Medtronic stock was at EUR 82.65 at Lang & Schwarz on October 13, 2026, at 8:10 a.m. CEST.
Pre-market indication
The Lang & Schwarz price was EUR 82.65 before the Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Medtronic stock.
What matters today
Medtronic expects to announce the final proration factor on October 14, 2026. A round-number level of EUR 100.00 is 20.99 percent above the Lang & Schwarz price of EUR 82.65. The exchange offer terms specify 4.5939 MiniMed shares for each accepted Medtronic ordinary share.
MiniMed exchange offer
According to the Medtronic release, the offer expired at the end of October 9, 2026. Medtronic said it would exchange 55,032,401 tendered shares for 252,813,348 MiniMed shares and accept tendered shares on a pro rata basis. It added that Medtronic would not retain any outstanding MiniMed shares after completion of the exchange offer.
Market context: Market report S&P 500.
